The Limitations of Research and Cardiac Arrest

RASK 9% difference as the primary outcome but no difference now out to one year in these patient centered outcomes of survival or not neurologic outcome. And it's also reassuring that as in an intensive care community we are not the only ones that struggle with the choice of the outcome for our trials. So my conclusion to this point is that research and cardiac arrest should not be avoided. In fact we should try to embrace some of the lessons learned from large in his team about accomplishing this large amazing trial.